Article
Short-Timescale Molecular Dynamics Assessment of Structural Stability in the EGFR–Erlotinib Complex Using the OPLS-AA Force Field
2026-05-06
Abstract excerpt
<title>Abstract</title> <p>Epidermal growth factor receptor (EGFR) overexpression and somatic kinase domain mutations are among the most actionable oncogenic drivers in non-small cell lung carcinoma. Erlotinib, a first-generation reversible EGFR inhibitor, competes with ATP at the kinase binding cleft and serves as a standard reference compound in computational studies of EGFR-directed therapy. Despite extensive...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c60e4cc4-8f80-59fd-9ec4-0b598c00116e
- DOI
- 10.21203/rs.3.rs-9584040/v1
